Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

LumiraDx Ltd (LMDXF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.020 -0.005    -21.00%
06/05 - Closed. Currency in USD ( Disclaimer )
After Hours
0.019
-0.001
-5.000%
20:55:21 - Delayed Data
  • Volume: 467,912
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.018 - 0.025
Type:  Equity
Market:  United States
LumiraDx 0.020 -0.005 -21.00%

LMDXF Recent Sentiments

 
User's sentiments regarding LumiraDx shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect LMDXF shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for LumiraDx.
Start Date Username Call Open Rate End Date Chg. %
Mar 21, 2024 Marco Messina   0.008 Apr 12, 2024 @ 0.015 -87.50%
Mar 01, 2024 Carlo Pellizzon   0.009 Mar 22, 2024 @ 0.008 -11.11%
Feb 12, 2024 พี่โมจิกะน้องเมธ เอ็ง   0.009 Mar 08, 2024 @ 0.009 0.00%
Jan 08, 2024 Pascal Boyer   0.019 Feb 02, 2024 @ 0.016 +15.79%
Jan 08, 2024 พี่โมจิกะน้องเมธ เอ็ง   0.017 Feb 02, 2024 @ 0.016 +5.88%
Jan 03, 2024 John soo   0.040 Jan 08, 2024 @ 0.016 -60.00%
Jan 03, 2024 Angelo Fortunato   0.043 Jan 08, 2024 @ 0.021 -51.16%
Dec 27, 2023 Mahmoud Mostafa   0.069 Jan 19, 2024 @ 0.013 +81.16%
Dec 27, 2023 Felix Salan De Castro   0.067 Jan 01, 2024 @ 0.063 +6.12%
Dec 26, 2023 yap HockGuan   0.066 Jan 19, 2024 @ 0.013 -80.30%
Dec 25, 2023 John soo   0.071 Dec 25, 2023 @ 0.071 +0.56%
Dec 14, 2023 พี่โมจิกะน้องเมธ เอ็ง   0.110 Jan 05, 2024 @ 0.034 +68.73%
Dec 12, 2023 antonio torres   0.127 Jan 05, 2024 @ 0.034 -72.91%
Dec 11, 2023 Andrey Panchenko   0.097 Jan 05, 2024 @ 0.034 -64.54%
Dec 04, 2023 Felix Salan De Castro   0.119 Dec 11, 2023 @ 0.096 +19.33%
Dec 04, 2023 Robbert Kuipers   0.133 Dec 29, 2023 @ 0.063 -52.71%
Dec 04, 2023 Robbert Kuipers   0.133 Dec 04, 2023 @ 0.133 0.00%
Dec 04, 2023 Felix Salan De Castro   0.125 Dec 04, 2023 @ 0.129 +3.20%
Dec 01, 2023 Renato Silva   0.131 Dec 22, 2023 @ 0.071 -45.80%
Dec 01, 2023 Bhargav Velani   0.129 Dec 04, 2023 @ 0.129 0.00%
Nov 30, 2023 Kadir Tekcan   0.175 Dec 22, 2023 @ 0.071 -59.43%
Nov 30, 2023 ALIK PINHAS   0.197 Nov 30, 2023 @ 0.214 +8.63%
Nov 20, 2023 Guillermo Vazquez   0.124 Dec 15, 2023 @ 0.101 -18.55%
Nov 16, 2023 Oliver Sipe   0.131 Nov 16, 2023 @ 0.131 0.00%
Nov 15, 2023 Roger Cedillos   0.095 Nov 16, 2023 @ 0.125 -31.58%
Nov 10, 2023 Daniel Batista   0.087 Nov 30, 2023 @ 0.117 +34.94%
Nov 06, 2023 Bee Wellinter   0.093 Nov 06, 2023 @ 0.093 0.00%
Nov 06, 2023 кирилл кузьмин   0.094 Dec 01, 2023 @ 0.117 +24.31%
Nov 06, 2023 Usman Khan   0.095 Dec 01, 2023 @ 0.117 +23.00%
Nov 06, 2023 Ольга Шарапова   0.090 Dec 01, 2023 @ 0.117 +29.83%
Nov 06, 2023 현학 김   0.090 Nov 30, 2023 @ 0.117 +30.44%
Nov 04, 2023 Abdullah KOÇ   0.096 Nov 30, 2023 @ 0.117 -22.29%
Nov 01, 2023 soapte mincinoase   0.082 Nov 02, 2023 @ 0.089 +8.54%
Oct 31, 2023 Bader Nafea   0.087 Nov 30, 2023 @ 0.117 -34.94%
Oct 27, 2023 gjergji kureta   0.122 Nov 30, 2023 @ 0.117 +3.77%
Oct 26, 2023 Cihan Çetinkaya   0.129 Nov 30, 2023 @ 0.117 +8.99%
Oct 26, 2023 Cihan Çetinkaya   0.124 Oct 26, 2023 @ 0.124 0.00%
Oct 26, 2023 Jan Smit   0.130 Oct 30, 2023 @ 0.089 -31.54%
Oct 24, 2023 Robbert Kuipers   0.154 Nov 30, 2023 @ 0.117 -23.77%
Oct 24, 2023 Malhi Sultan   0.152 Nov 30, 2023 @ 0.117 -22.76%
Oct 24, 2023 Zuheir Khalil   0.151 Nov 30, 2023 @ 0.117 -22.25%
Oct 24, 2023 Suhar Yanto   0.166 Nov 30, 2023 @ 0.117 -29.28%
Oct 23, 2023 Adrian Maciejek   0.252 Nov 30, 2023 @ 0.117 -53.41%
Oct 23, 2023 Robbert Kuipers   0.297 Oct 24, 2023 @ 0.154 -48.15%
Oct 23, 2023 Robbert Kuipers   0.297 Oct 23, 2023 @ 0.292 -1.68%
Oct 23, 2023 Michael Holt   0.270 Nov 30, 2023 @ 0.117 -56.52%
Oct 23, 2023 Илхомиддини Тоирзода   0.245 Oct 23, 2023 @ 0.250 +2.04%
Oct 23, 2023 Sébastien LE GOASCOZ   0.292 Nov 30, 2023 @ 0.117 -59.79%
Oct 05, 2023 Lluis de Cabo Lopez   0.203 Nov 30, 2023 @ 0.117 -42.17%
Oct 02, 2023 Сергей Ляхов   0.220 Nov 30, 2023 @ 0.117 -46.64%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

LMDXF Price Commentary

Write your thoughts about LumiraDx Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Albert Gb
Albert Gb Jan 04, 2024 16:42
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The Lumiradx Ltd share price will soon rise by 50% in January 2024 due to a number of factors, including: • FDA approval of its lung cancer diagnostic device, the LumiraDx Lung Cancer Assay. This device is a blood test that can detect lung cancer in its early stages, when it is most treatable. The FDA approval was a major milestone for the company and generated great enthusiasm among investors. • Expectations that the company will obtain more FDA approvals in the future. Lumiradx is developing a number of other diagnostic devices, including blood tests for breast cancer, ovarian cancer and Alzheimer's disease. Investors expect the company to obtain more FDA approvals in the coming years, which could lead to significant revenue growth. • The general increase in interest in medical technology companies. Investors are increasingly interested in companies that develop new technologies to diagnose and treat diseases. Lumiradx is one of the leading companies in the medical technology field, making it an attractive investment for investors. Notably, the rise in Lumiradx's stock price came after the company announced that its lung cancer diagnostic device, the LumiraDx Lung Cancer Assay, had received FDA approval. This approval will be an important milestone for the company, as it allows it to commercialize its device. The device is a blood test that can detect lung cancer in its early stages, when it is most treatable. The FDA approval of Lumiradx is an example of how medical technology companies can generate significant investor interest. Investors are increasingly interested in companies that develop new technologies to diagnose and treat diseases. Lumiradx is one of the leading companies in the medical technology field, making it an attractive investment for investors.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email